Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple programmes crossing crucial translational thresholds. And 2026 will only ...

Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined continued ...

It's a common storytelling trope: the stubborn foe who is eventually revealed to be a much-needed friend. Biology has its own version. Cornell researchers have discovered that DNA packaging structures ...

The POL price debate is entering a new chapter as analysts question whether Polygon’s long-anticipated “stablecoin supercycle” could be the catalyst that reverses its sluggish market performance. With ...